Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cancer Science|April 14, 2017
Downregulation of delta-aminolevulinate dehydratase is associated with poor prognosis in patients with breast cancerJie Ge, Yue Yu, Fei Xin, et al.
International Journal of Clinical and Experimental Medicine|May 2, 2015
Phase II multi-center clinical study on using S-1 to treat advanced breast cancer after resistance to anthracycline and taxane drugs in Chinese patientsPeng Yuan, Li-Jun Di, Wei Liu, et al.
Journal of Cellular Biochemistry|November 20, 2018
ACT001 can prevent and reverse tamoxifen resistance in human breast cancer cell lines by inhibiting NF-κB activationXiao-Han Jin, Yong-Sheng Jia, Ye-Hui Shi, et al.
Acta Pharmacologica Sinica|June 10, 2014
RIP3 overexpression sensitizes human breast cancer cells to parthenolide in vitro via intracellular ROS accumulationCan Lu, Li-Yan Zhou, Hui-Jun Xu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|January 29, 2009
[Docetaxel and capecitabine combination chemotherapy for patients with anthracycline-resistant metastatic breast cancer]Shu-Fen Li, Xu Wang, Chen Wang, et al.
Molecules (Basel, Switzerland)|April 26, 2016
Sulforaphane Analogues with Heterocyclic Moieties: Syntheses and Inhibitory Activities against Cancer Cell LinesYe-Hui Shi, Dong-Fang Dai, Jing Li, et al.
Chinese Medical Journal|April 12, 2012
Safety and efficacy of first-line bevacizumab combined with taxane therapy in Chinese patients with HER2-negative locally recurrent or metastatic breast cancer: findings from the ATHENA studyBing-he Xu, Ze-fei Jiang, Zhen-zhou Shen, et al.
Mycoses|October 22, 2020
Aetiology of superficial fungal infections of the foot in urban outpatients in mainland China: A multicentre, prospective case studyJin Yu, Wei-Da Liu, Zhong-Sheng Tong, et al.
The Lancet. Oncology|March 22, 2015
Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trialXi-Chun Hu, Jian Zhang, Bing-He Xu, et al.
Therapeutic Advances in Medical Oncology|November 5, 2020
MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2- advanced breast cancer: the multinational randomized phase III studyQing Yuan Zhang, Tao Sun, Yong Mei Yin, et al.
Pageof 3